If authorized, it would be the first long-acting drug for people with compromised immune systems who don't get sufficient protection from vaccination.
AstraZeneca, the drugmaker that developed one of the first Covid-19 vaccines, has asked the Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease.
Pangaloa said the company's long-acting formulation is designed to boost immunity for up to one year, compared with existing drugs that offer a month or two of protection.after a possible Covid exposure The FDA has stressed that antibody drugs are not a substitute for vaccination, which is the most effective, long-lasting form of virus protection. Antibody drugs also are expensive to produce and require an IV or injection and health care workers to administer.Late-stage human trials showed that AstraZeneca’s antibody drug reduced the risk of developing symptomatic COVID-19 by 77%.
The drugs are laboratory-made versions of virus-blocking antibodies that help fight off infections. The treatments help the patient by supplying concentrated doses of one or two antibodies.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Johnson & Johnson seeks FDA authorization of Covid booster shotJ&J said Monday that giving a second dose two months after the first increased protection against symptomatic moderate to severe Covid-19 to 94 percent, with 100 percent protection against severe illness.
Baca lebih lajut »
Johnson & Johnson Asks FDA to Authorize Covid-19 BoosterJohnson & Johnson has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot
Baca lebih lajut »
Johnson & Johnson asks FDA to authorize Covid-19 vaccine booster shotsJohnson & Johnson has asked the FDA to authorize booster shots for its coronavirus vaccine, but has left it up to the FDA and the US Centers for Disease Control and Prevention to decide just who should get their boosters and when.
Baca lebih lajut »
Former FDA commissioner says COVID-19 vaccine included in childhood immunization schedule is 'inevitable'Former Food and Drug Administration Commissioner Dr. Scott Gottlieb said he thinks it's 'inevitable that the COVID-19 vaccine is going to be incorporated into the childhood immunization schedule' in an interview on CBS's 'Face The Nation' Sunday.
Baca lebih lajut »
Johnson & Johnson Requests FDA Approval for Vaccine Booster DosesJohnson & Johnson asked the FDA on Tuesday to authorize an extra dose of its COVID-19 vaccine as a booster shot.
Baca lebih lajut »
Johnson & Johnson Submits Booster Shot Data To FDA For ApprovalThe company has released data suggesting the second shot offers strong protection against Covid-19.
Baca lebih lajut »